Future Thinking: The Next Generation Healthcare - Future Planet Capital

*|MC:SUBJECT|*

*|MC_PREVIEW_TEXT|*

March 2023 | View this email in your browser

The Next Generation Healthcare

Welcome to our latest edition of Future Thinking.

Last month the Future Planet Capital team were on-the-ground at Arab Health Week in Dubai. Executive Chairman Douglas Hansen-Luke was joined by Professor Adrian Hill, Director of University of Oxford’s Jenner Institute who helped create the AstraZeneca Covid-19 vaccine. The pair made a stop at the UK’s Department for International Trade (DIT)’s pavilion which brought together UK & UAE stakeholders and partners to explore collaborations between the two countries’ healthcare systems.

The key focus of the pavilion was the ‘Health of Digital Health’. It focused on the role of digital technology in revolutionising the way healthcare is delivered and how to realise accessible, affordable, and sustainable care. As a proud investor of Vaccitech, we understand the importance of advancing scientific research in healthcare innovation to deliver long-term and life-saving impact.

During the week we also had the pleasure of hosting a roundtable dinner on the future of vaccines in Dubai. Professor Hill and Lord Dominic Johnson of Lainston, Minister for Investment, were guests of honour among healthcare, technology and investment experts from the UK and the Middle East.

Together we explored the latest innovations that are advancing the development of vaccines, particularly focusing on the ongoing fight against Covid, malaria and MERS.

What is clear is the important role of investment in the scientific advancement of solutions for such diseases – a role that can be fulfilled by private venture capital.

Portfolio Spotlight – Vaccitech

When we came in as an investor of the University of Oxford’s spin-off biotechnology company, Vaccitech, the results of the COVID-19 vaccine trials were still unknown. This was back in 2020, when our understanding of the virus was limited.

At a time when Vaccitech was in need of fresh funding to fuel its growth, Future Planet Capital played a strategic role in reopening the investment round.

Today, Vaccitech is best known for the development of the Oxford-AstraZeneca COVID-19 vaccine. With over 3 billion doses delivered across more than 180 countries, the vaccine saved 6.3 million lives in the first year of its roll-out.

We’ve released the Wei Forward Report II

Finding solutions to global issues requires a radical overhaul of the policy framework behind impact investing. It is vital that we act now.

Lord Nat Wei and Douglas Hansen-Luke share their thoughts on how governments and industry can work together to unlock innovation.

Read the Wei Forward Report II here

Want to know more?
Contact E d Phillips or Abi Wye at Future Planet Capital.

This monthly digest is brought to you by Future Planet Capital.

This information is being communicated by Future Planet Capital (Ventures) Limited, which is authorised and regulated by the Financial Conduct Authority.This email message and any files transmitted with it are intended solely for the addressee(s) and are considered privileged and confidential. If you have received this email in error please (i) delete it and all copies of it from your system and (ii) destroy any hard copies of it. You should not divulge, copy, forward, or use the contents, attachments, or information in any way. Any unauthorized use or disclosure may be unlawful. Future Planet Capital gives no warranty as to the accuracy or completeness of email messages and accepts no responsibility for changes made after dispatch.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Spread the love